12.91 USD
-0.62
4.58%
Updated Apr 1, 3:22 PM EDT
1 day
-4.58%
5 days
-8.83%
1 month
-6.85%
3 months
-22.74%
6 months
-34.50%
Year to date
-22.74%
1 year
-55.08%
5 years
71.22%
10 years
-38.08%
 

About: The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

Employees: 6,000

0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 6 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

268% more call options, than puts

Call options by funds: $71.5M | Put options by funds: $19.4M

46% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 54

39% more repeat investments, than reductions

Existing positions increased: 140 | Existing positions reduced: 101

4% more funds holding

Funds holding: 418 [Q3] → 433 (+15) [Q4]

2.29% more ownership

Funds ownership: 82.54% [Q3] → 84.83% (+2.29%) [Q4]

14% less capital invested

Capital invested by funds: $2.5B [Q3] → $2.14B (-$362M) [Q4]

17% less funds holding in top 10

Funds holding in top 10: 6 [Q3] → 5 (-1) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$16
24%
upside
Avg. target
$22
70%
upside
High target
$27
109%
upside

6 analyst ratings

positive
50%
neutral
50%
negative
0%
Barclays
Michael Leithead
32% 1-year accuracy
6 / 19 met price target
24%upside
$16
Equal-Weight
Maintained
1 Apr 2025
Mizuho
John Roberts
34% 1-year accuracy
12 / 35 met price target
47%upside
$19
Outperform
Upgraded
27 Mar 2025
BMO Capital
John McNulty
34% 1-year accuracy
16 / 47 met price target
109%upside
$27
Outperform
Maintained
19 Feb 2025
Truist Securities
Peter Osterland
13% 1-year accuracy
1 / 8 met price target
109%upside
$27
Buy
Initiated
28 Jan 2025
Morgan Stanley
Vincent Andrews
50% 1-year accuracy
4 / 8 met price target
70%upside
$22
Equal-Weight
Maintained
13 Jan 2025

Financial journalist opinion

Based on 6 articles about CC published over the past 30 days

Negative
Zacks Investment Research
1 week ago
Why Is Chemours (CC) Down 14% Since Last Earnings Report?
Chemours (CC) reported earnings 30 days ago. What's next for the stock?
Why Is Chemours (CC) Down 14% Since Last Earnings Report?
Positive
Zacks Investment Research
1 week ago
Chemours Forms Partnership With Energy Fuels to Establish Supply Chain
CC & Energy Fuels team up to expand rare earth and critical mineral supply chains in the U.S. domestic market.
Chemours Forms Partnership With Energy Fuels to Establish Supply Chain
Neutral
PRNewsWire
2 weeks ago
Energy Fuels and Chemours Forming Strategic Alliance to Create a Domestic Supply Chain of Critical Minerals for the United States
DENVER , March 18, 2025 /PRNewswire/ - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) and The Chemours Company (NYSE: CC) today announced they are forming a strategic alliance to expand the companies' existing relationship to enhance U.S. domestic rare earth and critical mineral supply chains to meet increasing demand. The alliance will capitalize on the complementary geographic and operational synergies of both organizations.
Energy Fuels and Chemours Forming Strategic Alliance to Create a Domestic Supply Chain of Critical Minerals for the United States
Neutral
Business Wire
2 weeks ago
Chemours and Energy Fuels Forming Strategic Alliance to Create a Domestic Supply Chain of Critical Minerals for the United States
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours and Energy Fuels Forming Strategic Alliance to Create a Domestic Supply Chain of Critical Minerals for the United States.
Chemours and Energy Fuels Forming Strategic Alliance to Create a Domestic Supply Chain of Critical Minerals for the United States
Positive
Zacks Investment Research
2 weeks ago
Chemours, NTT DATA & Hibiya Engineering Join Forces for Product Trial
CC partners with industry leaders to address the data center cooling gap by conducting Opteon 2P50 product trials.
Chemours, NTT DATA & Hibiya Engineering Join Forces for Product Trial
Neutral
Business Wire
2 weeks ago
Chemours Joins Forces with NTT DATA and Hibiya Engineering, Ltd. For Full-Scale Opteon™ 2P50 Product Trial
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Joins Forces with NTT DATA and Hibiya Engineering, Ltd. For Full-Scale Opteon™ 2P50 Product Trial.
Chemours Joins Forces with NTT DATA and Hibiya Engineering, Ltd. For Full-Scale Opteon™ 2P50 Product Trial
Neutral
Zacks Investment Research
1 month ago
Chemours' Earnings Outpace Estimates, Revenues Miss in Q4
CC's sales fall modestly as a drop in pricing is largely offset by a gain in volume, while the currency impact remains unchanged in Q4.
Chemours' Earnings Outpace Estimates, Revenues Miss in Q4
Positive
Seeking Alpha
1 month ago
The Long-Term Upside For Chemours Company After Q4 2024
I've been investing in Chemours for years, despite recent accounting irregularities and share price decline since before 2024. Chemours, a leader in the titanium dioxide sector, also excels in new refrigerants like Opteon due to regulatory changes. Despite recent poor returns, I remain confident in Chemours' fundamentals and long-term potential, especially after 4Q24.
The Long-Term Upside For Chemours Company After Q4 2024
Neutral
Business Wire
1 month ago
Chemours Launches Ti-Pure™ TS-6706, A TMP/TME- Free Version of Flagship Universal Grade, Ti-Pure™ R-706
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Launches Ti-Pure™ TS-6706, A TMP/TME- Free Version of Flagship Universal Grade, Ti-Pure™ R-706.
Chemours Launches Ti-Pure™ TS-6706, A TMP/TME- Free Version of Flagship Universal Grade, Ti-Pure™ R-706
Neutral
Seeking Alpha
1 month ago
The Chemours Company (CC) Q4 2024 Earnings Call Transcript
The Chemours Company (NYSE:CC ) Q4 2024 Earnings Conference Call February 18, 2025 8:00 AM ET Company Participants Brandon Ontjes - VP of IR Denise Dignam - President and CEO Shane Hostetter - SVP and CFO Conference Call Participants Arun Viswanathan - RBC Capital Markets Josh Spector - UBS Hassan Ahmed - Alembic Global Advisors John McNulty - BMO Vincent Andrews - Morgan Stanley John Roberts - Mizuho Laurence Alexander - Jefferies Jeff Zekauskas - JPMorgan Pete Osterland - Truist Operator Good morning. My name is Michelle, and I will be your conference operator today.
The Chemours Company (CC) Q4 2024 Earnings Call Transcript
Charts implemented using Lightweight Charts™